Back to Stakeholders
McMaster University
Canada
1 Trial
A Canadian research university in Hamilton, Ontario, McMaster University houses the Centre for Medicinal Cannabis Research and an expanding psychedelic science program including the McMaster Psychedelic Research Society; the university is sponsoring the PSI_CUD trial—a Phase 2 proof-of-concept study of psilocybin-assisted psychotherapy (two 25mg doses within an 8-week Motivational Enhancement Therapy framework) for cannabis use disorder.
Quick Facts
- Type
- Other
- HQ
- Canada
- Website
- Visit